Description:

D-Artepp 80/640 is formulated to treat uncomplicated malaria caused by Plasmodium falciparum and other Plasmodium species. It combines two active ingredients: dihydroartemisinin and piperaquine phosphate, which work synergistically to eliminate malaria parasites from the bloodstream.

Prescription:

• Over-the-counter (OTC).

Therapeutic Category:

• Antimalarial.

Active Ingredients/Composition:

• Dihydroartemisinin: 80 mg
• Piperaquine phosphate: 640 mg

Each tablet contains 80 mg of dihydroartemisinin and 640 mg of piperaquine phosphate.

Variant:

• D-Artepp is available in tablet form with the specified dosage of 80 mg dihydroartemisinin and 640 mg piperaquine phosphate.

Consume Type:

• Oral tablets.

Directions/Usage:

The standard treatment involves administering the medication over three consecutive days, with one dose taken each day. The exact dosage depends on the patient’s body weight:

• 5 kg to less than 8 kg: 1 tablet per day
• 8 kg to less than 11 kg: 1½ tablets per day
• 11 kg to less than 17 kg: 2 tablets per day
• 17 kg to less than 25 kg: 3 tablets per day

For patients weighing more than 25 kg, higher strength tablets are available and should be used if required. It’s important to follow the dosing schedule as prescribed and consult a healthcare provider for specific instructions.

Common Side Effects:

Possible side effects include:

• Headache
• Dizziness
• Nausea
• Vomiting
• Abdominal pain
• Prolongation of the QT interval (a measure of heart rhythm)

Patients should seek medical attention if they experience any severe or concerning symptoms.

Package Type:

• D-Artepp tablets are typically packaged in blister packs, with each pack containing a complete treatment course for one individual.

Storage Advice:

• Store the medication in a cool, dry place away from direct sunlight. Keep out of reach of children.

Safety Advice:

• Consult a healthcare provider before starting treatment, especially if you have existing heart conditions or are taking other medications.
• Do not exceed the recommended dose.
• If a dose is vomited within 30 minutes of administration, the dose should be re-administered. If vomiting occurs between 30 to 60 minutes after dosing, half of the dose should be re-administered. Re-dosing should not be attempted more than once.

Product Substitutes:

Alternative antimalarial medications include:

• DuoCotecxin:
• Contains dihydroartemisinin and piperaquine, manufactured by Beijing Holley-Cotec Pharmaceutical Ltd, China.
• Eurartesim:
• A combination of dihydroartemisinin and piperaquine, manufactured by AlfaSigma (formerly Sigma-Tau).

Manufacturer/Marketer:

• Forsun Pharma

Country of Origin:

• China.